Grufity logo
Grufity logo

Latest JOHNSON & JOHNSON Stock Portfolio

$652Million– No. of Holdings #16

JOHNSON & JOHNSON Performance:
2026 Q1: 18.16%YTD: 18.16%2025: 51.06%
Performance for 2026 Q1 is 18.16%, and YTD is 18.16%, and 2025 is 51.06%.

About JOHNSON & JOHNSON and 13F Hedge Fund Stock Holdings

On 2026-05-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, JOHNSON & JOHNSON reported an equity portfolio of $652.4 Millions as of 31 Mar, 2026.

The top stock holdings of JOHNSON & JOHNSON are PTGX, NBTX, MGTX. The fund has invested 39.6% of it's portfolio in PROTAGONIST THERAPEUTICS INC. and 26.6% of portfolio in NANOBIOTIX S.A.

The fund managers got completely rid off RALLYBIO CORPORATION (RLYB) and LYELL IMMUNOPHARMA, INC. (LYEL) stocks. They significantly reduced their stock positions in NANO-X IMAGING LTD. (NNOX). JOHNSON & JOHNSON opened new stock positions in RALLYBIO CORPORATION (RLYB).
JOHNSON & JOHNSON Equity Portfolio Value
Last Reported on: 13 May, 2026

JOHNSON & JOHNSON Annual Return Estimates Vs S&P 500

Our best estimate is that JOHNSON & JOHNSON made a return of 18.16% in the last quarter. In trailing 12 months, it's portfolio return was 101.59%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
rallybio corporation1,371,520
New stocks bought by JOHNSON & JOHNSON

Additions

No additions were made to existing positions by JOHNSON & JOHNSON

Reductions

Ticker% Reduced
nano-x imaging ltd.-47.4
JOHNSON & JOHNSON reduced stake in above stock

Sold off

Ticker$ Sold
rallybio corporation-2,494,910
lyell immunopharma, inc.-1,689,420
JOHNSON & JOHNSON got rid off the above stocks

Sector Distribution

JOHNSON & JOHNSON has about 58% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare58
Others42

Market Cap. Distribution

JOHNSON & JOHNSON has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • SMALL-CAP
  • MICRO-CAP
Category%
UNALLOCATED42
MID-CAP39.6
SMALL-CAP11.6
MICRO-CAP6.6

Stocks belong to which Index?

About 58% of the stocks held by JOHNSON & JOHNSON either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200058
Others42
Top 5 Winners (%)%
VOR
vor biopharma, inc.
36.4 %
NBTX
nanobiotix s.a.
33.5 %
CVRX
cvrx, inc.
33.2 %
FATE
fate therapeutics, inc.
22.1 %
PTGX
protagonist therapeutics inc.
20.7 %
Top 5 Winners ($)$
PTGX
protagonist therapeutics inc.
44.2 M
NBTX
nanobiotix s.a.
43.6 M
CVRX
cvrx, inc.
9.5 M
MGTX
meiragtx holdings plc
4.7 M
contineum therapeutics inc.
3.2 M
Top 5 Losers (%)%
LAB
standard biotools, inc.
-28.2 %
XNCR
xencor, inc.
-21.2 %
PRCT
procept biorobotics corporation
-20.5 %
ACET
adicet bio, inc.
-19.1 %
LEGN
legend biotech corporation
-16.8 %
Top 5 Losers ($)$
LEGN
legend biotech corporation
-3.0 M
XNCR
xencor, inc.
-2.4 M
PRCT
procept biorobotics corporation
-2.3 M
LAB
standard biotools, inc.
-0.1 M
NNOX
nano-x imaging ltd.
-0.1 M

JOHNSON & JOHNSON Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of JOHNSON & JOHNSON

JOHNSON & JOHNSON has 16 stocks in it's portfolio. About 99% of the portfolio is in top 10 stocks. LEGN proved to be the most loss making stock for the portfolio. PTGX was the most profitable stock for JOHNSON & JOHNSON last quarter.

Last Reported on: 13 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions